Paper24944883
Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways.
Rathod SS and 4 others. FEBS Open Bio, 2014. Cited by 114 papers, by iCite.
Cite this record
ConductScience Library. Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways. Papers, record 24944883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24944883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20129251 | Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20129251 | PubMed |
| 2 | 23311594 | Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach. | EURASIP J Bioinform Syst Biol | 2013 | https://conductscience.org/library/papers/23311594 | PubMed |
| 3 | 21385897 | A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. | Cancer Res | 2011 | https://conductscience.org/library/papers/21385897 | PubMed |
| 4 | 23814265 | MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells. | Neuro Oncol | 2013 | https://conductscience.org/library/papers/23814265 | PubMed |
| 5 | 17297439 | MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. | Oncogene | 2007 | https://conductscience.org/library/papers/17297439 | PubMed |
| 6 | 21881409 | The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. | RNA Biol | 2011 | https://conductscience.org/library/papers/21881409 | PubMed |
| 7 | 20190569 | microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. | Cell Cycle | 2010 | https://conductscience.org/library/papers/20190569 | PubMed |
| 8 | 14965445 | A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers. | Neoplasia | 2003 | https://conductscience.org/library/papers/14965445 | PubMed |
| 9 | 18505919 | A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. | Mol Cancer Res | 2008 | https://conductscience.org/library/papers/18505919 | PubMed |
| 10 | 18669428 | Malignant gliomas in adults. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18669428 | PubMed |
| 11 | 23302469 | Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. | J Transl Med | 2013 | https://conductscience.org/library/papers/23302469 | PubMed |
| 12 | 18772890 | Comprehensive genomic characterization defines human glioblastoma genes and core pathways. | Nature | 2008 | https://conductscience.org/library/papers/18772890 | PubMed |
| 13 | 21728042 | MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme. | Mol Neurobiol | 2011 | https://conductscience.org/library/papers/21728042 | PubMed |
| 14 | 21240262 | The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. | Nat Med | 2011 | https://conductscience.org/library/papers/21240262 | PubMed |
| 15 | 22999562 | Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas. | J Clin Neurosci | 2012 | https://conductscience.org/library/papers/22999562 | PubMed |
| 16 | 23337036 | Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma. | Mol Cell Neurosci | 2013 | https://conductscience.org/library/papers/23337036 | PubMed |
| 17 | 19461653 | The miR-34 family in cancer and apoptosis. | Cell Death Differ | 2010 | https://conductscience.org/library/papers/19461653 | PubMed |
| 18 | 21557327 | Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells. | Mol Carcinog | 2011 | https://conductscience.org/library/papers/21557327 | PubMed |
| 19 | 18089801 | mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. | Cancer Res | 2007 | https://conductscience.org/library/papers/18089801 | PubMed |
| 20 | 22479456 | miR-34a repression in proneural malignant gliomas upregulates expression of its target PDGFRA and promotes tumorigenesis. | PLoS One | 2012 | https://conductscience.org/library/papers/22479456 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41721414 | Invasiveness-related microRNA expression in glioma: associations with clinical outcomes, tumor burden, and health-related quality of life. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41721414 | PubMed |
| 41313571 | Crossroads of cell fate: miR-34-mediated regulation of apoptosis and autophagy in glioblastoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41313571 | PubMed |
| 40898306 | Phenotypic variations in glioma stem cells: regulatory mechanisms and implications for therapeutic strategies. | J Transl Med | 2025 | https://conductscience.org/library/papers/40898306 | PubMed |
| 40789939 | Delphinidin upregulates microRNA-let-7b expression through family with sequence similarity 222 member B. | Sci Rep | 2025 | https://conductscience.org/library/papers/40789939 | PubMed |
| 38616694 | Bioinformatics Study and Experimental Evaluation of miR-182, and miR-34 Expression Profiles in Tuberculosis and Lung Cancer. | Tuberc Respir Dis (Seoul) | 2024 | https://conductscience.org/library/papers/38616694 | PubMed |
| 38473776 | Glioblastoma Therapy: Past, Present and Future. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473776 | PubMed |
| 38406506 | MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia. | EJHaem | 2024 | https://conductscience.org/library/papers/38406506 | PubMed |
| 38291993 | Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a. | Mol Pharm | 2024 | https://conductscience.org/library/papers/38291993 | PubMed |
| 38059120 | Engineered smart materials for RNA based molecular therapy to treat Glioblastoma. | Bioact Mater | 2024 | https://conductscience.org/library/papers/38059120 | PubMed |
| 37686489 | Exploring the Role of microRNAs in Glioma Progression, Prognosis, and Therapeutic Strategies. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37686489 | PubMed |
| 37686362 | Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686362 | PubMed |
| 36951490 | Anti-tumor effects of miR-34a by regulating immune cells in the tumor microenvironment. | Cancer Med | 2023 | https://conductscience.org/library/papers/36951490 | PubMed |
| 36660602 | Quercetin up-regulates the expression of tumor-suppressive microRNAs in human cervical cancer. | Biosci Microbiota Food Health | 2023 | https://conductscience.org/library/papers/36660602 | PubMed |
| 36321132 | Non-coding RNAs and glioma: Focus on cancer stem cells. | Mol Ther Oncolytics | 2022 | https://conductscience.org/library/papers/36321132 | PubMed |
| 36014370 | 67-kDa Laminin Receptor-Mediated Cellular Sensing System of Green Tea Polyphenol EGCG and Functional Food Pairing. | Molecules | 2022 | https://conductscience.org/library/papers/36014370 | PubMed |
| 35846075 | MicroRNAs as prognostic markers and therapeutic targets in gliomas. | Noncoding RNA Res | 2022 | https://conductscience.org/library/papers/35846075 | PubMed |
| 35804989 | The Role of microRNAs in Multidrug Resistance of Glioblastoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35804989 | PubMed |
| 35681635 | Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681635 | PubMed |
| 35430703 | NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis. | J Neurooncol | 2022 | https://conductscience.org/library/papers/35430703 | PubMed |
| 35371310 | miR-145-5p inhibits the proliferation of glioma stem cells by targeting translationally controlled tumor protein. | J Cancer | 2022 | https://conductscience.org/library/papers/35371310 | PubMed |
Genes45
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24944883
GET https://conductscience.org/api/papers/v1/24944883/references?page=2